Haemonetics Corp. buy BTIG Research
Start price
09.01.26
/
50%
€72.00
Target price
09.01.27
€75.54
Performance (%)
-31.39%
Price
02.04.26
€49.40
Summary
This prediction is currently active. Massive losses of -31.39% have been the result for the BUY prediction by BTIG_Research. This prediction currently runs until 09.01.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.106% | 5.106% |
| iShares Core DAX® | 4,85 % | -2,75 % |
| iShares Nasdaq 100 | 4,00 % | -3,33 % |
| iShares Nikkei 225® | 4,22 % | -2,91 % |
| iShares S&P 500 | 3,32 % | -2,95 % |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€67.50
21.11.25
21.11.25
€76.29
21.11.26
21.11.26
-26.81%
02.04.26
02.04.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
-14.09%
02.04.26
02.04.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25